Beam Therapeutics Ownership 2024 | Who Owns Beam Therapeutics Now?
Institutional Ownership
94.90%
Insider Ownership
1.49%
Retail Ownership
3.61%
Institutional Holders
218.00
Beam Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 9.69% | 0.87% | 7,913,123 | 3,401,370 | 75.39% | 185,404,472 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.67% | 0.00% | 7,900,379 | 321,611 | 4.24% | 185,105,879 | Jun 30, 2024 |
| BLACKROCK INC. | 9.34% | 0.00% | 7,634,379 | 928,753 | 13.85% | 178,873,499 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 9.33% | 1.59% | 7,626,139 | -556,035 | -6.80% | 178,680,431 | Jun 30, 2024 |
| ARCH VENTURE MANAGEMENT, LLC | 6.66% | 47.94% | 5,443,039 | 5,443,039 | 100.00% | 127,530,404 | Jun 30, 2024 |
| FMR LLC | 5.40% | 0.01% | 4,407,695 | -486,758 | -9.95% | 103,272,299 | Jun 30, 2024 |
| STATE STREET CORP | 4.27% | 0.00% | 3,492,155 | -239,037 | -6.41% | 81,821,192,000 | Jun 30, 2024 |
| MWG MANAGEMENT LTD. | 2.77% | 58.01% | 2,266,934 | -80,000 | -3.41% | 53,114,264 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 2.72% | 0.04% | 2,224,415 | -137,402 | -5.82% | 52,118,043 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.72% | 0.60% | 2,224,415 | -137,402 | -5.82% | 52,073,555 | Jun 30, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 2.22% | 0.20% | 1,812,972 | - | - | 42,477,934 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.12% | 0.00% | 1,729,581 | 92,859 | 5.67% | 40,531,472 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 2.08% | 2.41% | 1,703,061 | -176,556 | -9.39% | 39,902,719 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 1.81% | 0.04% | 1,482,271 | 1,482,271 | 100.00% | 34,729,609 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 1.74% | 0.54% | 1,418,121 | 225,000 | 18.86% | 33,226,575 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.71% | 0.00% | 1,393,673 | 147,484 | 11.83% | 32,655,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.28% | 0.01% | 1,049,360 | 407,499 | 63.49% | 24,589,062 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.06% | 0.01% | 861,993 | 801,238 | 1318.80% | 20,196,496 | Jun 30, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1.03% | 1.60% | 845,500 | - | - | 19,810,065 | Jun 30, 2024 |
| MORGAN STANLEY | 0.98% | 0.00% | 803,829 | -3,319,746 | -80.51% | 18,833,726 | Jun 30, 2024 |
Beam Therapeutics's largest institutional shareholder is FARALLON CAPITAL MANAGEMENT LLC, holding 9.69% of the company's total share outstanding, currently valued at $185.40M. The top 10 institutional shareholders own together 62.59% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MWG MANAGEMENT LTD. | 2.77% | 58.01% | 2,266,934 | -80,000 | -3.41% | 53,114,264 | Jun 30, 2024 |
| ARCH VENTURE MANAGEMENT, LLC | 6.66% | 47.94% | 5,443,039 | 5,443,039 | 100.00% | 127,530,404 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 2.08% | 2.41% | 1,703,061 | -176,556 | -9.39% | 39,902,719 | Jun 30, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1.03% | 1.60% | 845,500 | - | - | 19,810,065 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 9.33% | 1.59% | 7,626,139 | -556,035 | -6.80% | 178,680,431 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 0.83% | 1.21% | 675,000 | - | - | 15,815,250 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 9.69% | 0.87% | 7,913,123 | 3,401,370 | 75.39% | 185,404,472 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.33% | 0.64% | 270,000 | 270,000 | 100.00% | 6,326,100 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.72% | 0.60% | 2,224,415 | -137,402 | -5.82% | 52,073,555 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 1.74% | 0.54% | 1,418,121 | 225,000 | 18.86% | 33,226,575 | Jun 30, 2024 |
| ALPHABET INC. | 0.39% | 0.38% | 321,604 | - | - | 7,535,182 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.09% | 0.32% | 72,800 | 72,800 | 100.00% | 1,705,704 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.03% | 0.27% | 21,964 | 21,964 | 100.00% | 514,617 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.06% | 0.25% | 51,876 | 32,469 | 167.31% | 1,215,455 | Jun 30, 2024 |
| GREEN ALPHA ADVISORS, LLC | 0.01% | 0.22% | 11,777 | -1,859 | -13.63% | 275,935 | Jun 30, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 2.22% | 0.20% | 1,812,972 | - | - | 42,477,934 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.31% | 0.18% | 249,923 | 102,413 | 69.43% | 5,855,696 | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.18% | 0.14% | 144,554 | - | - | 3,386,900 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.02% | 0.13% | 13,755 | 13,755 | 100.00% | 322,280 | Jun 30, 2024 |
| CLARIUS GROUP, LLC | 0.07% | 0.10% | 60,615 | - | - | 1,420,209 | Jun 30, 2024 |
The largest Beam Therapeutics shareholder by % of total assets is MWG MANAGEMENT LTD.. The company owns 2.27M shares of Beam Therapeutics (BEAM), representing 58.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 6.66% | 47.94% | 5,443,039 | 5,443,039 | 100.00% | 127,530,404 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 9.69% | 0.87% | 7,913,123 | 3,401,370 | 75.39% | 185,404,472 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 1.81% | 0.04% | 1,482,271 | 1,482,271 | 100.00% | 34,729,609 | Jun 30, 2024 |
| BLACKROCK INC. | 9.34% | 0.00% | 7,634,379 | 928,753 | 13.85% | 178,873,499 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.06% | 0.01% | 861,993 | 801,238 | 1318.80% | 20,196,496 | Jun 30, 2024 |
| NORGES BANK | 0.50% | 0.00% | 410,799 | 410,799 | 100.00% | 9,625,021 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.28% | 0.01% | 1,049,360 | 407,499 | 63.49% | 24,589,062 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.67% | 0.00% | 7,900,379 | 321,611 | 4.24% | 185,105,879 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.33% | 0.64% | 270,000 | 270,000 | 100.00% | 6,326,100 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.96% | 0.00% | 784,563 | 232,351 | 42.08% | 18,382,311 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 1.74% | 0.54% | 1,418,121 | 225,000 | 18.86% | 33,226,575 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.84% | 0.00% | 690,065 | 224,579 | 48.25% | 16,168,222 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.01% | 174,180 | 174,180 | 100.00% | 4,084,460 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.18% | 0.00% | 151,066 | 151,066 | 100.00% | 3,682,988 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.71% | 0.00% | 1,393,673 | 147,484 | 11.83% | 32,655,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.47% | 0.03% | 382,995 | 146,608 | 62.02% | 8,973,573 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.51% | 0.00% | 419,569 | 121,223 | 40.63% | 9,830,500 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.31% | 0.18% | 249,923 | 102,413 | 69.43% | 5,855,696 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.12% | 0.00% | 1,729,581 | 92,859 | 5.67% | 40,531,472 | Jun 30, 2024 |
| LIONTRUST INVESTMENT PARTNERS LLP | 0.10% | 0.03% | 80,000 | 80,000 | 100.00% | 1,874,400 | Jun 30, 2024 |
As of Jun 30 2024, Beam Therapeutics's largest institutional buyer is ARCH VENTURE MANAGEMENT, LLC. The company purchased 5.44M stocks of BEAM, valued at $127.53M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 0.98% | 0.00% | 803,829 | -3,319,746 | -80.51% | 18,833,726 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | - | - | - | -2,119,598 | -100.00% | - | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 9.33% | 1.59% | 7,626,139 | -556,035 | -6.80% | 178,680,431 | Jun 30, 2024 |
| FMR LLC | 5.40% | 0.01% | 4,407,695 | -486,758 | -9.95% | 103,272,299 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.01% | 0.00% | 9,656 | -292,364 | -96.80% | 226,240 | Jun 30, 2024 |
| STATE STREET CORP | 4.27% | 0.00% | 3,492,155 | -239,037 | -6.41% | 81,821,192,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.15% | 0.01% | 120,765 | -238,033 | -66.34% | 2,829,524 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 2,457 | -221,472 | -98.90% | 58,919 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -195,000 | -100.00% | - | Jun 30, 2024 |
| REDMILE GROUP, LLC | 2.08% | 2.41% | 1,703,061 | -176,556 | -9.39% | 39,902,719 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.72% | 0.60% | 2,224,415 | -137,402 | -5.82% | 52,073,555 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 2.72% | 0.04% | 2,224,415 | -137,402 | -5.82% | 52,118,043 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 0.76% | 0.01% | 623,640 | -128,754 | -17.11% | 14,611,885 | Jun 30, 2024 |
| UBS GROUP AG | 0.20% | 0.00% | 162,577 | -87,664 | -35.03% | 3,809,180 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -81,220 | -100.00% | - | Jun 30, 2024 |
| MWG MANAGEMENT LTD. | 2.77% | 58.01% | 2,266,934 | -80,000 | -3.41% | 53,114,264 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.20% | 0.01% | 165,264 | -79,090 | -32.37% | 3,872,136 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | - | - | - | -77,880 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -55,649 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Beam Therapeutics's biggest institutional seller is MORGAN STANLEY. The company sold -3.32M shares of BEAM, valued at $18.83M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 6.66% | 47.94% | 5,443,039 | 5,443,039 | 100.00% | 127,530,404 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 1.81% | 0.04% | 1,482,271 | 1,482,271 | 100.00% | 34,729,609 | Jun 30, 2024 |
| NORGES BANK | 0.50% | 0.00% | 410,799 | 410,799 | 100.00% | 9,625,021 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.01% | 174,180 | 174,180 | 100.00% | 4,084,460 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.18% | 0.00% | 151,066 | 151,066 | 100.00% | 3,682,988 | Jun 30, 2024 |
| LIONTRUST INVESTMENT PARTNERS LLP | 0.10% | 0.03% | 80,000 | 80,000 | 100.00% | 1,874,400 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.09% | 0.32% | 72,800 | 72,800 | 100.00% | 1,705,704 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.07% | 0.00% | 59,095 | 59,095 | 100.00% | 1,384,596 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 41,134 | 41,134 | 100.00% | 963,770 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.05% | 0.00% | 41,076 | 41,076 | 100.00% | 962,411 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.05% | 0.00% | 37,500 | 37,500 | 100.00% | 878,625 | Jun 30, 2024 |
| EISLER CAPITAL (US) LLC | 0.04% | 0.01% | 34,378 | 34,378 | 100.00% | 805,477 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.06% | 31,810 | 31,810 | 100.00% | 745,308 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.04% | 0.00% | 30,000 | 30,000 | 100.00% | 12,000 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.03% | 0.01% | 24,399 | 24,399 | 100.00% | 571,669 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.03% | 0.00% | 20,839 | 20,839 | 100.00% | 488,258,000 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.02% | 0.00% | 14,341 | 14,341 | 100.00% | 331,544 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.02% | 0.13% | 13,755 | 13,755 | 100.00% | 322,280 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | 0.00% | 12,417 | 12,417 | 100.00% | 290,000 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.01% | 11,393 | 11,393 | 100.00% | 267,000 | Jun 30, 2024 |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 0.01% | 0.02% | 9,303 | 9,303 | 100.00% | 217,969 | Jun 30, 2024 |
| MARTINGALE ASSET MANAGEMENT L P | 0.01% | 0.00% | 8,929 | 8,929 | 100.00% | 209,207 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | 0.01% | 0.04% | 8,800 | 8,800 | 100.00% | 206,184 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.01% | 0.00% | 8,721 | 8,721 | 100.00% | 204,333 | Jun 30, 2024 |
| STATE OF WYOMING | 0.01% | 0.02% | 6,193 | 6,193 | 100.00% | 145,102 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 35,145 | Jun 30, 2024 |
| 0.00% | 0.01% | 1,105 | 1,105 | 100.00% | 25,890 | Jun 30, 2024 | |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 239 | 239 | 100.00% | 5,599 | Jun 30, 2024 |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | 0.00% | 0.00% | 97 | 97 | 100.00% | 2,272 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 90 | 90 | 100.00% | 2,109 | Jun 30, 2024 |
| VERSANT CAPITAL MANAGEMENT, INC | 0.00% | 0.00% | 64 | 64 | 100.00% | 1,500 | Jun 30, 2024 |
| 0.00% | 0.00% | 50 | 50 | 100.00% | 1,365 | Jun 30, 2024 | |
| CVA FAMILY OFFICE, LLC | - | 0.00% | 22 | 22 | 100.00% | 515 | Jun 30, 2024 |
| JFS WEALTH ADVISORS, LLC | - | - | 14 | 14 | 100.00% | 329 | Jun 30, 2024 |
| SJS INVESTMENT CONSULTING INC. | - | - | 2 | 2 | 100.00% | 47 | Jun 30, 2024 |
Beam Therapeutics's largest new institutional shareholder by number of shares is ARCH VENTURE MANAGEMENT, LLC, purchased 5.44M shares, valued at $127.53M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | - | - | - | -2,119,598 | -100.00% | - | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -195,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -81,220 | -100.00% | - | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | - | - | - | -77,880 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -55,649 | -100.00% | - | Jun 30, 2024 |
| POINT72 HONG KONG LTD | - | - | - | -48,325 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -47,000 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -37,955 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -36,760 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -34,641 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -30,196 | -100.00% | - | Jun 30, 2024 |
| BAMCO INC /NY/ | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -26,486 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -23,166 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -20,400 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -18,853 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -18,622 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -15,496 | -100.00% | - | Jun 30, 2024 |
| PEARL RIVER CAPITAL, LLC | - | - | - | -15,429 | -100.00% | - | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | - | - | - | -14,932 | -100.00% | - | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -14,700 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -11,864 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -10,734 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -10,700 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -8,803 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -8,475 | -100.00% | - | Jun 30, 2024 |
| BRANDYWINE MANAGERS, LLC | - | - | - | -8,067 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -7,894 | -100.00% | - | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | - | - | - | -7,630 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -7,626 | -100.00% | - | Jun 30, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | - | - | - | -7,225 | -100.00% | - | Jun 30, 2024 |
| THRIVE WEALTH MANAGEMENT, LLC | - | - | - | -6,925 | -100.00% | - | Jun 30, 2024 |
| MCGUIRE INVESTMENT GROUP, LLC | - | - | - | -6,250 | -100.00% | - | Jun 30, 2024 |
| REYNDERS MCVEIGH CAPITAL MANAGEMENT, LLC | - | - | - | -6,055 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,847 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -3,200 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -2,800 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -2,453 | -100.00% | - | Jun 30, 2024 |
| SPIRE WEALTH MANAGEMENT | - | - | - | -225 | -100.00% | - | Jun 30, 2024 |
| TRUST CO OF VERMONT | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| RALEIGH CAPITAL MANAGEMENT INC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| CASSADY SCHILLER WEALTH MANAGEMENT, LLC | - | - | - | -84 | -100.00% | - | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -80 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
| ASSETMARK, INC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
Beam Therapeutics's largest sold out institutional shareholder by shares sold is DARWIN GLOBAL MANAGEMENT, LTD., sold -2.12M shares, valued at -, as of undefined.
Beam Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Ark ETF Trust | 1.02% | 8,205,123 | -364,328 | -4.25% | Jan 31, 2024 |
| Manager Directed Portfolios | 0.70% | 114,002 | - | - | Jan 31, 2024 |
| Kelly Strategic ETF Trust | 0.45% | 12,306 | - | - | Feb 29, 2024 |
| Ark Venture Fund | 0.19% | 17,951 | 5,447 | 43.56% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.10% | 51,311 | - | - | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.09% | 10,281 | - | - | Mar 31, 2024 |
| Vanguard Montgomery Funds | 0.06% | 14,971 | 14,971 | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 152,291 | 116,513 | 325.66% | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.05% | 236,893 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,272,351 | -53,984 | -4.07% | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.04% | 94,845 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.03% | 15,817 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 280,000 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.03% | 718 | -115 | -13.81% | Dec 31, 2023 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.03% | 23,223 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.03% | 8,229 | -4,371 | -34.69% | Dec 31, 2023 |
| ALGER FUNDS | 0.03% | 29,561 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.03% | 15,710 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.03% | 255,200 | - | - | Jan 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 88,706 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.03% | 6,741 | 6,741 | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.02% | 8,809 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.02% | 13,483 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 56,000 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 127,243 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 27,819 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,996 | -48 | -0.43% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,158,150 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 3,131 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 6,264,149 | -1,087,715 | -14.80% | Mar 31, 2024 |
| ACAP Strategic Fund | 0.01% | 213,102 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 53,200 | - | - | Jan 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.01% | 91,200 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 32,717 | 527 | 1.64% | Feb 29, 2024 |
| Jacob Funds Inc. | 0.01% | 2,188 | -2,527 | -53.59% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,758 | - | - | Mar 31, 2024 |
| Harbor ETF Trust | 0.01% | 35,335 | 4,255 | 13.69% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 82,900 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.01% | 154,953 | 154,953 | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 442,725 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 25,183 | -5,594 | -18.18% | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 26,003 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 38,992 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 211,265 | 5,531 | 2.69% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.00% | 14,653 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 8,000 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.00% | 3,320 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 691,843 | 49,675 | 7.74% | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 37,652 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 63,170 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 26,576 | - | - | Mar 28, 2024 |
| BARON SELECT FUNDS | 0.00% | 30,000 | 14,283 | 90.88% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,503 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 26,412 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 23,830 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 5,289 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 2,712 | -665 | -19.69% | Dec 31, 2023 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 13,683 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 8,884 | 5,925 | 200.24% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 326,171 | 59,073 | 22.12% | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 100,000 | - | - | Feb 29, 2024 |
| Listed Funds Trust | 0.00% | 9,597 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,755 | 2,755 | - | Jan 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 1,292 | - | - | Sep 30, 2023 |
| Destra Investment Trust | 0.00% | 2,714 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 46,670 | -816 | -1.72% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,435 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 51,770 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 12,984 | -6,667 | -33.93% | Mar 31, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 47,552 | - | - | Feb 29, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.00% | 3,600 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 245,111 | 11,619 | 4.98% | Feb 29, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 129,469 | -82,598 | -38.95% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 6,310 | - | - | Aug 31, 2023 |
| Capitol Series Trust | 0.00% | 8,400 | - | - | Jan 31, 2024 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 5,005 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 9,832 | 2,811 | 40.04% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 23,895 | -4,677 | -16.37% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 3,820 | - | - | Mar 28, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,552 | 110 | 3.20% | Mar 31, 2024 |
| Global X Funds | 0.00% | 31,757 | -88,139 | -73.51% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,533 | -702 | -7.60% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 13,077 | -576 | -4.22% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 288,032 | 79,283 | 37.98% | Jan 31, 2024 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 44,955 | -2,905 | -6.07% | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 1,593 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 33,232 | 26,408 | 386.99% | Mar 31, 2024 |
| Spinnaker ETF Series | 0.00% | 245 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 370,380 | 27,103 | 7.90% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 71,690 | 30,332 | 73.34% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 13,564 | 539 | 4.14% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 291 | - | - | Apr 30, 2021 |
| Federated Hermes Equity Funds | 0.00% | 10,000 | - | - | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 4,873 | 4,873 | - | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,624 | 2,624 | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 6,156 | -244 | -3.81% | Mar 31, 2023 |
| FundVantage Trust | 0.00% | 7,142 | 7,482 | -2200.59% | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 83,761 | -105 | -0.13% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 27,200 | 1,000 | 3.82% | Mar 31, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 13,281 | - | - | Jan 31, 2024 |
Beam Therapeutics's largest mutual fund holder by % of total assets is "Ark ETF Trust", owning 8.21M shares, compromising 1.02% of its total assets.
Beam Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 218 | -6.44% |
| 31 Mar, 24 | 233 | 20.10% |
| 31 Dec, 23 | 194 | -2.51% |
| 30 Sep, 23 | 199 | -1.00% |
| 30 Jun, 23 | 201 | -6.94% |
| 31 Mar, 23 | 216 | -3.14% |
| 31 Dec, 22 | 223 | -3.04% |
| 30 Sep, 22 | 230 | 13.86% |
| 30 Jun, 22 | 202 | -16.87% |
| 31 Mar, 22 | 243 | 2.53% |
| 31 Dec, 21 | 237 | 0.42% |
| 30 Sep, 21 | 236 | -3.28% |
| 30 Jun, 21 | 244 | 8.93% |
| 31 Mar, 21 | 224 | 36.59% |
| 31 Dec, 20 | 164 | 95.24% |
| 30 Sep, 20 | 84 | 18.31% |
| 30 Jun, 20 | 71 | 18.33% |
| 31 Mar, 20 | 60 | - |
As of 30 Jun 24, 218 institutions are holding Beam Therapeutics's shares, representing a decrease of -6.44% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 77,530,666 | 10.73% |
| 31 Mar, 24 | 70,020,592 | 1.73% |
| 31 Dec, 23 | 68,826,550 | 2.56% |
| 30 Sep, 23 | 67,108,904 | 4.58% |
| 30 Jun, 23 | 64,166,997 | 6.35% |
| 31 Mar, 23 | 60,338,222 | 7.94% |
| 31 Dec, 22 | 55,900,625 | 2.53% |
| 30 Sep, 22 | 54,522,189 | -0.42% |
| 30 Jun, 22 | 54,754,315 | 11.29% |
| 31 Mar, 22 | 49,201,278 | 8.06% |
| 31 Dec, 21 | 45,532,487 | 0.84% |
| 30 Sep, 21 | 45,153,704 | -0.70% |
| 30 Jun, 21 | 45,471,088 | 6.40% |
| 31 Mar, 21 | 42,736,312 | 15.80% |
| 31 Dec, 20 | 36,905,480 | 25.00% |
| 30 Sep, 20 | 29,524,623 | 6.56% |
| 30 Jun, 20 | 27,707,888 | 3.05% |
| 31 Mar, 20 | 26,888,544 | - |
Beam Therapeutics (BEAM) has 77.53M shares outstanding as of 30 Jun 24, up 10.73% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 94.90% | 1.15% |
| 31 Mar, 24 | 90.76% | 1.20% |
| 31 Dec, 23 | 87.09% | 1.13% |
| 30 Sep, 23 | 87.91% | 1.12% |
| 30 Jun, 23 | 88.78% | 1.27% |
| 31 Mar, 23 | 83.49% | 1.31% |
| 31 Dec, 22 | 79.84% | 1.33% |
| 30 Sep, 22 | 77.51% | 1.27% |
| 30 Jun, 22 | 77.99% | 1.52% |
| 31 Mar, 22 | 71.61% | 1.60% |
| 31 Dec, 21 | 66.97% | 1.45% |
| 30 Sep, 21 | 68.03% | 1.27% |
| 30 Jun, 21 | 73.09% | 1.45% |
| 31 Mar, 21 | 70.98% | 1.89% |
| 31 Dec, 20 | 61.29% | 1.76% |
| 30 Sep, 20 | 58.95% | 1.88% |
| 30 Jun, 20 | 56.05% | 0.73% |
| 31 Mar, 20 | 87.51% | - |
As of 30 Jun 24, Beam Therapeutics is held by 94.90% institutional shareholders, representing a 1.15% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 107 | -21.90% |
| 31 Mar, 24 | 137 | 33.01% |
| 31 Dec, 23 | 103 | -7.21% |
| 30 Sep, 23 | 111 | 11.00% |
| 30 Jun, 23 | 100 | -5.66% |
| 31 Mar, 23 | 106 | -7.02% |
| 31 Dec, 22 | 114 | -4.20% |
| 30 Sep, 22 | 119 | 0.85% |
| 30 Jun, 22 | 118 | -17.48% |
| 31 Mar, 22 | 143 | 19.17% |
| 31 Dec, 21 | 120 | -10.45% |
| 30 Sep, 21 | 134 | -5.63% |
| 30 Jun, 21 | 142 | 6.77% |
| 31 Mar, 21 | 133 | 7.26% |
| 31 Dec, 20 | 124 | 121.43% |
| 30 Sep, 20 | 56 | 27.27% |
| 30 Jun, 20 | 44 | -26.67% |
| 31 Mar, 20 | 60 | - |
107 institutional shareholders have increased their position in BEAM stock as of 30 Jun 24 compared to 137 in the previous quarter (a -21.90% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 62 | 31.91% |
| 31 Mar, 24 | 47 | -11.32% |
| 31 Dec, 23 | 53 | 26.19% |
| 30 Sep, 23 | 42 | - |
| 30 Jun, 23 | 42 | -27.59% |
| 31 Mar, 23 | 58 | -1.69% |
| 31 Dec, 22 | 59 | -7.81% |
| 30 Sep, 22 | 64 | 64.10% |
| 30 Jun, 22 | 39 | -11.36% |
| 31 Mar, 22 | 44 | -34.33% |
| 31 Dec, 21 | 67 | 45.65% |
| 30 Sep, 21 | 46 | -4.17% |
| 30 Jun, 21 | 48 | 14.29% |
| 31 Mar, 21 | 42 | 425.00% |
| 31 Dec, 20 | 8 | -20.00% |
| 30 Sep, 20 | 10 | - |
| 30 Jun, 20 | 10 | - |
| 31 Mar, 20 | - | - |
62 institutional shareholders have reduced their position in BEAM stock as of 30 Jun 24 compared to 47 in the previous quarter (a 31.91% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 218 | -6.44% | 77,530,666 | 10.73% | 94.90% | 1.15% | 107 | -21.90% | 62 | 31.91% |
| 31 Mar, 24 | 233 | 20.10% | 70,020,592 | 1.73% | 90.76% | 1.20% | 137 | 33.01% | 47 | -11.32% |
| 31 Dec, 23 | 194 | -2.51% | 68,826,550 | 2.56% | 87.09% | 1.13% | 103 | -7.21% | 53 | 26.19% |
| 30 Sep, 23 | 199 | -1.00% | 67,108,904 | 4.58% | 87.91% | 1.12% | 111 | 11.00% | 42 | - |
| 30 Jun, 23 | 201 | -6.94% | 64,166,997 | 6.35% | 88.78% | 1.27% | 100 | -5.66% | 42 | -27.59% |
| 31 Mar, 23 | 216 | -3.14% | 60,338,222 | 7.94% | 83.49% | 1.31% | 106 | -7.02% | 58 | -1.69% |
| 31 Dec, 22 | 223 | -3.04% | 55,900,625 | 2.53% | 79.84% | 1.33% | 114 | -4.20% | 59 | -7.81% |
| 30 Sep, 22 | 230 | 13.86% | 54,522,189 | -0.42% | 77.51% | 1.27% | 119 | 0.85% | 64 | 64.10% |
| 30 Jun, 22 | 202 | -16.87% | 54,754,315 | 11.29% | 77.99% | 1.52% | 118 | -17.48% | 39 | -11.36% |
| 31 Mar, 22 | 243 | 2.53% | 49,201,278 | 8.06% | 71.61% | 1.60% | 143 | 19.17% | 44 | -34.33% |
| 31 Dec, 21 | 237 | 0.42% | 45,532,487 | 0.84% | 66.97% | 1.45% | 120 | -10.45% | 67 | 45.65% |
| 30 Sep, 21 | 236 | -3.28% | 45,153,704 | -0.70% | 68.03% | 1.27% | 134 | -5.63% | 46 | -4.17% |
| 30 Jun, 21 | 244 | 8.93% | 45,471,088 | 6.40% | 73.09% | 1.45% | 142 | 6.77% | 48 | 14.29% |
| 31 Mar, 21 | 224 | 36.59% | 42,736,312 | 15.80% | 70.98% | 1.89% | 133 | 7.26% | 42 | 425.00% |
| 31 Dec, 20 | 164 | 95.24% | 36,905,480 | 25.00% | 61.29% | 1.76% | 124 | 121.43% | 8 | -20.00% |
| 30 Sep, 20 | 84 | 18.31% | 29,524,623 | 6.56% | 58.95% | 1.88% | 56 | 27.27% | 10 | - |
| 30 Jun, 20 | 71 | 18.33% | 27,707,888 | 3.05% | 56.05% | 0.73% | 44 | -26.67% | 10 | - |
| 31 Mar, 20 | 60 | - | 26,888,544 | - | 87.51% | - | 60 | - | - | - |
Beam Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Beam Therapeutics's stock was made by Simon Amy on Jul 03 2024, selling 502 shares at $23.76 per share (valued at $11.93K).
Beam Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2033 | 1 | - | - |
| Q3 2024 | - | 2 | - |
| Q2 2024 | 12 | 7 | 171.43% |
| Q1 2024 | 10 | 7 | 142.86% |
| Q4 2023 | 4 | 8 | 50.00% |
| Q3 2023 | 3 | 6 | 50.00% |
| Q2 2023 | 5 | 11 | 45.45% |
| Q1 2023 | 21 | 29 | 72.41% |
| Q4 2022 | 3 | 15 | 20.00% |
| Q3 2022 | 16 | 8 | 200.00% |
| Q2 2022 | 4 | 9 | 44.44% |
| Q1 2022 | 7 | 16 | 43.75% |
| Q4 2021 | 6 | 20 | 30.00% |
| Q3 2021 | 19 | 47 | 40.43% |
| Q2 2021 | 31 | 48 | 64.58% |
| Q1 2021 | 25 | 27 | 92.59% |
| Q4 2020 | 2 | 21 | 9.52% |
| Q3 2020 | 3 | 2 | 150.00% |
| Q2 2020 | 1 | 1 | 100.00% |
| Q1 2020 | 19 | 29 | 65.52% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Beam Therapeutics's insiders, as of Q2 2033.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2033 | - | - | - |
| Q3 2024 | - | 2 | - |
| Q2 2024 | - | 7 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 4 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | 11 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 11 | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | 5 | - |
| Q1 2022 | - | 15 | - |
| Q4 2021 | - | 14 | - |
| Q3 2021 | - | 31 | - |
| Q2 2021 | - | 27 | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | - | 19 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
As of Q2 2033, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Beam Therapeutics's stocks.
Beam Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| SANA | Sana Biotechnology, Inc. |
| DNA | Ginkgo Bioworks Holdings, Inc. |
| CRSP | CRISPR Therapeutics AG |
| VRTX | Vertex Pharmaceuticals Incorporated |
| FATE | Fate Therapeutics, Inc. |
| NTLA | Intellia Therapeutics, Inc. |
| EDIT | Editas Medicine, Inc. |
| PRME | Prime Medicine, Inc. |
| VERV | Verve Therapeutics, Inc. |
| CRBU | Caribou Biosciences, Inc. |
BEAM Ownership FAQ
Who Owns Beam Therapeutics?
Beam Therapeutics is owned by institutional shareholders (94.90%), insiders (1.49%), and public (3.61%). The largest institutional shareholder of Beam Therapeutics is FARALLON CAPITAL MANAGEMENT LLC (9.69% of total shares) and the top mutual fund owner is Ark ETF Trust (1.02% of total shares).
Who are the major institutional shareholders of Beam Therapeutics?
Beam Therapeutics's major institutional shareholders are FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BLACKROCK INC., ARK INVESTMENT MANAGEMENT LLC, and ARCH VENTURE MANAGEMENT, LLC. The top five shareholders own together 44.70% of the company's share outstanding.
How many Beam Therapeutics shareholders are there?
As of Jun 2024, there are 218 institutional shareholders of Beam Therapeutics.
What percentage of Beam Therapeutics is owned by FARALLON CAPITAL MANAGEMENT LLC?
FARALLON CAPITAL MANAGEMENT LLC owns 7.91M shares of Beam Therapeutics, representing 9.69% of the company's total shares outstanding, valued at $185.4M (as of Jun 2024).
What percentage of Beam Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 7.9M shares of Beam Therapeutics (BEAM), compromising 9.67% of the company, valued at $185.11M.
What percentage of Beam Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Beam Therapeutics. The company owns 7.63M of the company's shares outstanding (worth $178.87M).